SukovWRChevilleJCCarlsonAW. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder. Mod Pathol2007; 20: 592–603.
2.
GleasonBCHornickJL. Inflammatory myofibroblastic tumours: Where are we now?J Clin Pathol2008; 61: 428–437.
3.
MontgomeryEAShusterDDBurkartAL. Inflammatory myofibroblastic tumors of the urinary tract: A clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol2006; 30: 1502–1512.
4.
CoffinCFletcherJ. Inflammatory myofibroblastic tumour. In: FletcherCUnniKKMertensF (eds) World Health Organization classification of tumours: Pathology & genetics: Tumours of soft tissue and bone. Lyon, France: IARC Press, 2002, 91–93.
5.
HarikLRMerinoCCoindreJM. Pseudosarcomatous myofibroblastic proliferations of the bladder: A clinicopathologic study of 42 cases. Am J Surg Pathol2006; 30: 787–794.